Kenya vs Russia: The number of people with susceptibility test result for rifampicin
Kenya
24,832
in 2021
Russia
21,391
in 2021
Kenya rank
13th
Russia rank
15th
The number of people with susceptibility test result for rifampicin over time
- Kenya
- Russia
How they compare
Kenya currently reports 24,832 against 21,391 in Russia, a difference of 3,441.
That makes Kenya's figure about 1.2 times Russia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Russia ahead.
Kenya ranks 13th and Russia ranks 15th of 155 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kenya | Russia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29,916 | 27,743 | 2,173 | Kenya |
| 2020s | 28,802 | 21,245 | 7,556 | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kenya or Russia?
- Kenya, at 24,832 against 21,391 in Russia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kenya and Russia?
- 3,441, with Kenya ahead.
- How many years of comparable data are there for Kenya and Russia?
- 5 years are reported by both, from 2017 to 2021.
- How do Kenya and Russia rank globally for the number of people with susceptibility test result for rifampicin?
- Kenya ranks 13th and Russia ranks 15th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.